European study seeks clues to mysterious eye bulge in severe myopia
NCT ID NCT06949579
First seen Jun 24, 2026 · Last updated Aug 07, 2026 · Updated 3 times
Summary
This study looks at 200 highly myopic adults in France, the Netherlands, and Spain to understand why some develop a condition called posterior staphyloma, where the back of the eye bulges outward. Researchers will analyze blood samples and eye images to find genetic and molecular differences between those with and without the condition. The goal is to better understand the causes, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve understanding of why some highly myopic people develop posterior staphyloma, potentially guiding future screening or prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to new therapies, and findings might not apply to non-European populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cochin Hospital
RECRUITINGParis, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could eye pigment levels predict vision damage in severe nearsightedness?
- AI boosts cataract surgery precision for severely nearsighted patients
- 60,000 eyes tracked: scientists hunt genes behind cataract outcomes
- Eye drops may halt worsening nearsightedness in adults
- Can a nightly eye drop tame severe nearsightedness in kids?
- AI eye scanner could predict blindness risk in nearsighted patients